Runaway Pharma Marketing Gets “Normalized”
October 15, 2014
Last month, Dublin-based drugmaker Shire made headlines for its pending acquisition by AbbVie, a deal that many saw as a new data point in the growing trend of corporate tax inversions. On Tuesday, following news that the White House was cracking down on tax inversions, AbbVie ...